Brandes Investment Partners LP Boosts Stock Holdings in LENSAR, Inc. (NASDAQ:LNSR)

Brandes Investment Partners LP lifted its holdings in LENSAR, Inc. (NASDAQ:LNSR) by 12.8% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 373,198 shares of the company’s stock after purchasing an additional 42,250 shares during the period. Brandes Investment Partners LP’s holdings in LENSAR were worth $1,644,000 at the end of the most recent quarter.

Separately, DCF Advisers LLC raised its stake in LENSAR by 1.4% in the second quarter. DCF Advisers LLC now owns 241,484 shares of the company’s stock worth $1,087,000 after buying an additional 3,250 shares in the last quarter. 40.15% of the stock is currently owned by institutional investors.

LENSAR Stock Up 3.2 %

LENSAR stock opened at $4.58 on Tuesday. The firm has a market cap of $52.20 million, a P/E ratio of -2.90 and a beta of 0.64. The business has a fifty day moving average of $4.59 and a two-hundred day moving average of $4.20. LENSAR, Inc. has a twelve month low of $1.80 and a twelve month high of $5.60.

LENSAR (NASDAQ:LNSR) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.53) earnings per share for the quarter. LENSAR had a negative return on equity of 30.69% and a negative net margin of 27.83%. The company had revenue of $12.64 million for the quarter.

About LENSAR

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.